购物车
- 全部删除
- 您的购物车当前为空
ZYF0033是一种口服有效的造血祖细胞激酶1(HPK1)小分子抑制剂,能够抑制MBP蛋白的磷酸化。HPK1-IN-22通过降低SLP76(丝氨酸76)的磷酸化,具有抑制肿瘤生长和介导免疫反应的潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
ZYF0033是一种口服有效的造血祖细胞激酶1(HPK1)小分子抑制剂,能够抑制MBP蛋白的磷酸化。HPK1-IN-22通过降低SLP76(丝氨酸76)的磷酸化,具有抑制肿瘤生长和介导免疫反应的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,080 | 现货 | |
5 mg | ¥ 1,820 | 现货 | |
25 mg | ¥ 7,500 | 现货 | |
50 mg | ¥ 9,750 | 现货 | |
100 mg | ¥ 16,500 | 现货 |
产品描述 | ZYF0033 is an orally effective small molecule inhibitor of hematopoietic progenitor kinase 1 (HPK1) that inhibits the phosphorylation of MBP proteins.HPK1-IN-22 promotes anticancer immune responses by decreasing the phosphorylation of SLP76 (serine 76), and has the potential to inhibit tumor growth and mediate immune responses. |
别名 | ZYF 0033, HPK1-IN-22 |
分子量 | 462.61 |
分子式 | C26H30N4O2S |
CAS No. | 2380300-79-6 |
Smiles | OC(C#CC1=CC=CC(=C1)COC=2C=C(C=NC2N)C=3SC(=NC3)C4CCN(C)CC4)(C)C |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (172.93 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容